Prognostic Value of c-MET Expression in Patients with Pancreatic Cancer Receiving Adjuvant and Neoadjuvant Chemoradiation Therapy

Chemoradiation therapy improves local control for pancreatic cancer, however, its benefit is lessened by the high metastatic potential of this disease. Biomarkers of distant progression could be used to determine the appropriate sequencing of adjuvant therapies.

http://ift.tt/2zMXp2L